CN108721340A - A kind of single-composition Chinese medicine preparation and its preparation method and application - Google Patents

A kind of single-composition Chinese medicine preparation and its preparation method and application Download PDF

Info

Publication number
CN108721340A
CN108721340A CN201710259043.5A CN201710259043A CN108721340A CN 108721340 A CN108721340 A CN 108721340A CN 201710259043 A CN201710259043 A CN 201710259043A CN 108721340 A CN108721340 A CN 108721340A
Authority
CN
China
Prior art keywords
weight
chinese medicine
sucrose
group
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710259043.5A
Other languages
Chinese (zh)
Inventor
姚辉涛
刘凡磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEIHAI HAOTONG MEDICAL SCIENCE AND TECHNOLOGY Co Ltd
Original Assignee
WEIHAI HAOTONG MEDICAL SCIENCE AND TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEIHAI HAOTONG MEDICAL SCIENCE AND TECHNOLOGY Co Ltd filed Critical WEIHAI HAOTONG MEDICAL SCIENCE AND TECHNOLOGY Co Ltd
Priority to CN201710259043.5A priority Critical patent/CN108721340A/en
Publication of CN108721340A publication Critical patent/CN108721340A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a kind of single-composition Chinese medicine preparations and its preparation method and application, which is characterized in that the cmm of simple prescription is prepared using the cicada fungus active ingredient of artificial culture as primary raw material.Cmm of simple prescription provided by the invention has apparent treatment and prevention effect to the generation and development of chronic renal failure.Animal experiments show that cmm of simple prescription provided by the invention can improve renal function, reduction serum creatinine and urea nitrogen levels, the deposition for improving hemoglobin, reducing ECM, mitigate renal tubular-interstitial injury, delays kidney region fibrosis;The folk prescription safely and effectively, without obvious toxic-side effects.

Description

A kind of single-composition Chinese medicine preparation and its preparation method and application
Technical field
The invention belongs to Chinese medicines and natural medicine technical field, and in particular to it is a kind of prevention and treatment chronic renal failure and its The single-composition Chinese medicine preparation and its preparation method and application of his chronic kidney disease.
Background technology
Chronic renal failure (CRF) is chronic renal disease and involves chronic kidney function caused by renal system disease It can decline, and the syndrome that the various clinical symptoms generated therefrom and metabolic disorder are formed.CRF is a kind of serious harm The difficult and complicated illness of patient body health or even life-threatening.A large amount of clinical and experimental studies confirmations, the chronic kidney disease of different pathogeny After kidney is by a degree of destruction, although its underlying pathology has stopped, renal function can still continue to decline.Cause How this carries out early prevention and treatment, and delay the disease progression of CRF to CRF, and reducing uremic incidence just seems particularly heavy It wants.
Recent study finds that natural medicinal entomogenous fungi cicada fungus has the synthesis for reducing extracellular matrix, delays kidney small Ball hardens, and improves the effect of renal function, but natural cicada fungus is faced with scarcity of resources, expensive, the production cycle is long, low output Problem.It was discovered by researchers that the artificial culture object of cicada fungus not only have effects that with natural cicada fungus similar ingredient and, especially exist It treats in chronic renal failure, it is same that there are reduction serum creatinine and urea nitrogen levels, improve renal function, inhibits proliferation of mesangial cells Increase with matrix, delays the hardening of glomerulus to be in progress, while the scarcity of resources of natural cicada fungus, low output, quality can also be solved The problems such as unstable.
Invention content
It is an object of the invention to overcome the deficiencies of existing technologies, a kind of single-composition Chinese medicine preparation is provided.The Chinese medicine preparation pair Chronic renal failure and the generation of other chronic kidney diseases have apparent treatment and prevention effect with development, can reduce serum xanthine Oxidase active.
To achieve the above object, the present invention adopts the following technical scheme that:
A kind of single-composition Chinese medicine preparation contains the artificial cultured products of cicada fungus in the single-composition Chinese medicine preparation.
Preferably, the artificial cultured products of cicada fungus comprise the following steps:
1) prepared by strain:It is prepared and level-one kind preparation process including inclined-plane kind;
Wherein, prepared by inclined-plane kind includes the following steps:Paecilomyces cicadae bacterial strain after unit cell is detached is transplanted to PSA medium slants It in test tube, is cultivated 5~7 days at 22 DEG C~25 DEG C, selects the good kind of growing way and save backup;
Prepared by level-one kind includes the following steps:Inclined-plane kind is accessed in potato sucrose culture solution, at 22 DEG C~25 DEG C, oscillation frequency Rate is cultivated 3~7 days under conditions of being 130~150r/min, until spare as level-one kind after occurring a large amount of mycelium pellets in conical flask;
2) it is inoculated with:Level-one kind obtained in step 1) is linked into solid medium;
3) it ferments:Culture box after inoculation moves in culturing room, under conditions of 20 DEG C~25 DEG C, relative humidity 60%~80% Culture 30 days~50 days;
4) harvesting of coremium:When the coremium height of culture has a small amount of conidium to occur up to 9cm or so, surface Harvesting.
Preferably, in step 1), (contain in per 1000ml culture mediums) containing following component in the PSA culture mediums:Horse Bell potato 200g, sucrose 20g, agar 20g, preparation method are:Peeled potatoes are diced to be placed in container and add water 1000ml, are boiled 20min~30min is boiled, sucrose and agar is added in filtering, supplies water to 1000ml, dissolves by heating, then dispense to test tube, Loading amount is the 1/5~1/4 of test tube length, and tampon, is placed in autoclave the 30min that sterilizes under 0.15MPa pressure beyond the Great Wall, while hot by test tube It is placed on skewback cooling.
Preferably, in step 1), (contain in per 1000ml culture solutions containing following component in the potato sucrose culture solution Have):Potato 200g, sucrose 20g;Preparation method is:Peeled potatoes are diced to be placed in container and add water 1000ml, are boiled Sucrose is added in 15min~30min, filtering, supplies water to 1000ml, dissolves by heating, then dispense to conical flask, loading amount is The 20%~30% of conical flask capacity, tampon beyond the Great Wall, then wrapped up with brown paper, it is placed in autoclave and sterilizes under 0.15MPa pressure 30min, taking-up are cooled to 20 DEG C or less.
Preferably, in step 2), the step of inoculation, is:When the temperature for cultivating the solid medium in box is cooled to 20 DEG C or less after, be aseptically inoculated with, according to 3~5% inoculum concentration by level-one kind access culture box in.
Preferably, in step 2), the raw material components of the solid medium include:
42~46 parts by weight of matrix;
2~10 parts by weight of bagasse;
0.1~0.5 parts by weight of oyster shell whiting;
2~5 parts by weight of dried silkworm chrysalis meal;
0.1~0.5 parts by weight of potassium nitrate;
44~56 parts by weight of water;
Wherein, the one kind of the matrix in following combination:The mixture of corn flour, wheat bran and sucrose;Wheat;Barley;Grain With the mixture of sucrose;The mixture of rice and sucrose;The mixture of sorghum and sucrose.
Preferably, in the mixture of the corn flour, wheat bran and sucrose, with the mixing of the corn flour, wheat bran and sucrose The weight percent of the total weight of object, corn flour, wheat bran and sucrose is respectively:Corn flour 43%~55%, wheat bran 44%~ 55%, sucrose 1%~2%.
Preferably, in the mixture of the grain and sucrose, with the total weight of the grain and the mixture of sucrose, grain and sugarcane Sugar weight percent be respectively:Grain 98%~99%, sucrose 1%~2%.
Preferably, in the mixture of the rice and sucrose, with the total weight of the rice and the mixture of sucrose, greatly Rice and the weight percent of sucrose are respectively:Rice 98%~99%, sucrose 1%~2%.
Preferably, high with the total weight of the sorghum and the mixture of sucrose in the mixture of the sorghum and sucrose The weight percent of fine strain of millet and sucrose is respectively:Sorghum 98%~99%, sucrose 1%~2%.
Preferably, the preparation method of the solid medium is:First by corn flour, wheat bran or wheat, barley, grain, rice, Sorghum is cooked, and sucrose, potassium nitrate are dissolved in water, then with bagasse, oyster shell whiting, dried silkworm chrysalis meal is proportionally uniformly mixed.
Preferably, peptone (fish meal), and the parts by weight of the peptone (fish meal) are also contained in the solid medium For 0.5 parts by weight.
Preferably, in step 2), the carbon-nitrogen ratio of the solid medium is 80~98.
Preferably, in step 3), daylighting is required in solid fermentation later stage coremium growth phase, temperature is compared with mycelial growth Slightly lower 2 DEG C of temperature, needs to maintain the circulation of air in incubation.
Preferably, in step 4), the harvesting the specific steps are:Remove breathable sealing film, is taken culture with tool Go out and detach coremium, drying classification is vacuum-packed after dry with bag film, mycoplasma is placed in -20 DEG C of storages.
The artificial cultured products of heretofore described cicada fungus are by coremium, conidium, mycelium and culture medium residue The mixture of matter.
It is further preferred that the artificial cultured products of cicada fungus refer to using Paecilomyces cicadae bacterial strain CGMCC No.3453 The artificial cultured products that [Paecilomyces cicadae] is obtained after above-mentioned solid culture, the bacterial strain is in November, 2009 Preservation was registered in China Committee for Culture Collection of Microorganisms's common micro-organisms center (abbreviation CGMCC) in 18th, preserving number is CGMCC No.3453。
The present invention also provides the preparation method of the single-composition Chinese medicine preparation, the preparation method is in following three kinds It is a kind of:
1) it crushes:It will directly be crushed after the artificial cultured products drying of cicada fungus, cross 120 mesh sieve and be made;
2) solvent extraction;
3) the cicada fungus artificial culture object is added water to cook (institute's water consumption is 3-6 times of cicada fungus artificial culture object weight), filtering, It is concentrated into right amount, is drying to obtain xeraphium.
Preferably, the solvent extraction is to be extracted using organic solvent, or carried for water, or is the mixing of organic solvent and water Solution extracts, and further preferably water carries.
Preferably, one or more mixtures of the organic solvent in ethyl alcohol, acetone and petroleum ether;It is described to have The mixed solution of solvent and water is the extract of ethanol water.
Preferably, in the preparation method that the cicada fungus artificial culture object adds water to cook, the decoction number is 2~3 times, often Secondary decocting time is 0.5~1 hour.
Preferably, in the preparation method that the cicada fungus artificial culture object adds water to cook, the decocting liquid obtained after the decoction is first 80 mesh sieve is crossed, removal of impurities is filtered.
Preferably, in the preparation method that the cicada fungus artificial culture object adds water to cook, the concentration is decompression film concentration, The drying is spray drying.
The third aspect of the invention provides a kind of Chinese medicine composition, which contains safe and effective amount The weight percentage of above-mentioned folk prescription Chinese medicine and pharmaceutically acceptable carrier, the folk prescription Chinese medicine is 50%-99%, preferably 62%-80%.
Pharmaceutically acceptable carrier is various pharmaceutically common auxiliary materials and/or excipient, including but not limited to sugar Class (such as lactose, dextrose and saccharose), starch (such as cornstarch and potato starch), cellulose and its derivates (such as carboxymethyl Sodium cellulosate, ethyl cellulose and methylcellulose), tragacanth gum powder, malt, gelatin, talcum, kollag is (such as tristearin Acid and magnesium stearate), calcium sulfate, vegetable oil is polynary such as peanut oil, cottonseed oil, sesame oil, olive oil, corn oil and cupu oil Alcohol (such as propylene glycol, glycerine, D-sorbite, mannitol and polyethylene glycol), alginic acid, emulsifier (such as Tween), wetting agent (such as NaLS), colorant, flavoring agent, tablet agent, stabilizer, antioxidant, preservative, apirogen water, isotonic salt Solution and phosphate buffer etc.;These substances be used to help as needed formula stability or help to improve activity or it Biological effectiveness or acceptable mouthfeel or smell are generated in the case of oral.
Any conventional dosage form can be made in the single-composition Chinese medicine preparation of the present invention according to the universal method in pharmacy, Including oral preparation.Preferably tablet, pulvis agent, granule, pill, pulvis, syrup, most preferably pulvis.
The single-composition Chinese medicine preparation pulvis of the present invention, preferable taking dose are 2-15g/ days, and optimal dosage is 5-10g/ It.
The fourth aspect of the invention provides the purposes of above-mentioned single-composition Chinese medicine preparation, i.e., the folk prescription Chinese medicine is used to prepare Treatment and the drug of prevention chronic renal failure and other chronic kidney diseases.Other described chronic kidney diseases refer to being damaged with renal tubulointerstitial Nephrosis based on evil, including uric acid nephropathy, chronic pyelonephritis, drug-induced renal impairment etc..
The fifth aspect of the invention provides the purposes of above-mentioned single-composition Chinese medicine preparation, i.e., the folk prescription Chinese medicine is used to prepare Treatment and prevention can reduce the drug of serum creatinine and urea nitrogen.
Term explanation:Heretofore described cicada fungus artificial culture object, that is, Paecilomyces cicadae, Latin are entitled Paecilomycescicadae。
Animal experiments show that folk prescription Chinese medicine provided by the invention can improve renal function, improve hemoglobin, reduce ECM Deposition, reduce proliferation of mesangial cells, mitigate Renal tissues damage, delay kidney region fibrosis;Its drug activity and natural cicada fungus Effect is compared to similar or more preferable, and safety is without obvious toxic-side effects.
In the present invention, the single-composition Chinese medicine preparation is made of the raw material, refers to directly being crushed or being carried by the raw material It takes and is made.
Specific implementation mode
Present invention will be further explained below with reference to specific examples.It should be understood that these embodiments are merely to illustrate the present invention Rather than it limits the scope of the invention.
The artificial culture of 1 single-composition Chinese medicine preparation of embodiment
Picking Paecilomyces cicadae strain accesses in PSA culture solutions, 22 DEG C -25 DEG C, spare after being cultivated 3-5 days under conditions of 140rpm; Seed is accessed according to 3-5% ratios in solid medium, 20 DEG C -25 DEG C, 30d- is cultivated under relative air humidity 60%-80% 50d, later stage coremium growth phase require daylighting, 2 DEG C slightly lower compared with the mycelial growth stage of temperature that need to open in due course daily Window is ventilated, and keeps culture room air fresh.
The PSA Medium Proportions that present embodiment uses is per 1000ml culture mediums:Potato 200g, sucrose 20g, agar 20g。
Solid medium proportioning described in present embodiment is 46 parts by weight of matrix, 5 parts by weight of bagasse, oyster shell whiting 0.4 Parts by weight, 2.5 parts by weight of dried silkworm chrysalis meal, 0.1 parts by weight of potassium nitrate, water are 44 parts by weight;Its mesostroma is wheat.Preparation method For:First wheat is cooked, sucrose, potassium nitrate are dissolved in water, then with bagasse, oyster shell whiting, dried silkworm chrysalis meal proportionally mixes Uniformly.
One of the preparation method of 2 single-composition Chinese medicine preparation of embodiment.
By the fresh cicada fungus artificial culture object of harvesting, 70 DEG C of dry 10h are crushed by pulverizer, cross 120 mesh screens, i.e., Obtain xeraphium.
The two of the preparation method of 3 single-composition Chinese medicine preparation of embodiment.
Water is added to decoct altogether 2 times the cicada fungus artificial culture object, 0.5 hour every time, decocting liquid removed impurity elimination using vacuum filtration Matter, obtains filtrate, and decompression film is concentrated into right amount, is spray-dried up to xeraphium.
The renal function of the 5/6 rat remnant model of single-composition Chinese medicine preparation pair of 4 embodiment 2 of embodiment.
The present embodiment data quoted from:Zhu Rong, Chen Yi-ping, Deng Yueyi, Wang Lin solid culture CSM treateds delay glomerulus hard Change the experimental study of Function and its mechanisms, Chinese combination of Chinese tradiational and Western medicine nephrosis magazine, 2005,6 (2):70-74.
Positive control drug:Cozaar, the production of Hangzhou Mo Shadong pharmaceutical Co. Ltds;Natural cicada fungus, the place of production are Zhejiang.
Experimental animal:SPF grades of male SD rats 70, at 2 monthly ages, 200 ± 10g of weight is tested by Shanghai Univ. of Traditional Chinese Medicine Animal center provides.
Grouping and modeling:SD rats adaptable fed is randomly divided into 2 groups after 1 week:Blank group (sham-operation group) 8 and reality Test group (operation group) 62.Experimental rat model is established using 5/6 kidney major part cutting method:1st operation, operation group rat Left kidney always cuts off 2/3 that cortex renis weight accounts for left kidney weight;The 2nd operation is carried out after 7d, right kidney is cut entirely.Two operations are for cutting Except the 5/6 of two kidney total weights.Sham-operation group SD rats expose kidney using same step, detach kidney peplos, but the not nephrectomy. Operation group animal survives 54, sham-operation group all survivals 8.2 weeks after the 2nd operation, all animal row inner canthus sound Arteries and veins clump is taken a blood sample, and is carried out serum creatinine (Scr) and is detected.And by 54 operation group rats, it is divided into 5 groups according to Scr stratified randoms:Model pair According to group (model group) 12, Cozaar group 10, natural cicada fungus group 11, artificial cicada fungus large dosage group (A groups) 10, artificial cicada Flower small dose group (B groups) 11.Cozaar group, natural cicada fungus group, artificial cicada fungus large dosage group (A groups), artificial cicada fungus are low dose of Start medicine feed, treatment time 42d within 4 weeks after group (B groups) rat is performed the operation at the 2nd time.Survival of rats 44, do evil through another person at the end of experiment Art group, each 8 of artificial cicada fungus large dosage group (A groups), model group, Cozaar group, natural cicada fungus group, artificial cicada fungus small dose group (B Group) it is 7 each.
Dosage:Natural cicada fungus group, artificial cicada fungus large dosage group (A groups) rat press 4gkg-1·d-1Dosage, manually Cicada fungus small dose group (B groups) presses 2gkg-1·d-1Dosage is added in feed and is administered, and often daily physiological saline gavage 1 time;Section Plain subgroup rat uses administration by gavage, by 30mgkg-1·d-1Dosage is dissolved in physiological saline, daily gavage 1 time.All rats It is grouped sub-cage rearing, per 4-5 rat of cage, whole rat free waters, feed commercially available blocky-shaped particle normal diet during experiment.
Test equipment and method:The Scr, urea nitrogen (BUN), albumin (Alb) of all rats are detected at the end of experiment;It receives Collect urine for 24 hours, measures quantity of proteinuria.The above index is measured using 7170 type automatic biochemistry analyzer of Hitachi.
Glomerulosclerosis is checked with HE dyeing and PAS dyeing renal pathology pieces, wherein glomerulosclerosis is defined as capillary Lumen of vessels collapses and/or hyalinization.Glomerulosclerosis degree is only assessed using the semi-quantitative method of Rajj etc..Light microscopic (× 200) under the visual field, every slice at least observes 40 glomerulus, is divided into 0-+++ according to glomerulus ratio shared by glomerulosclerosis stove +, 0 indicates glomerulus without hardening, and the 25% of 1 glomerulus of+expression is impaired, ++ indicate that 26%-50% is impaired, +++ indicate 51%- 75% is impaired, ++++indicate that 76%-100% is impaired.Then glomerulosclerosis index (GSI) is calculated.
Data statistics is carried out using 11.0 for Windows of SPSS Version, is indicated with mean ± standard deviation, group Between compare using One-Way ANOVA analyze, statistical significance level be P < 0.05.
Test result:As a result, it has been found that Scr, BUN value of rat, each treatment group significantly reduces (P < 0.05) compared with model group, Artificial cicada fungus each group (large dosage of group, small dose group) no difference of science of statistics (P > 0.05) compared with natural cicada fungus, the blood of rat is white Protein value, sham-operation group, Cozaar group, natural cicada fungus group, artificial cicada fungus large dosage group (A groups) significantly increase (P < 0.05), And artificial cicada fungus large dosage group (A groups) no difference of science of statistics (P > 0.05) compared with natural cicada fungus group and sham-operation group;Rat Urine albumen amount for 24 hours, each group obviously increase (P < 0.05) compared with sham-operation group, but Cozaar group, natural cicada fungus group, artificial Cicada fungus large dosage group (A groups) then significantly reduces (P < 0.05) compared with model group.
Conventional H E and PAS dyeing, the variation of light microscopic observation renal pathology:Rats in sham-operated group glomerulus blood vessels open It puts, clear in structure, glomerulus collagen is in thin-line-shaped distribution after PAS dyeing;Severe in model group rats glomerular mesangium territorial matrix Increase with severe hyperplasia in mesangial cell, part Capillary loops, which are pressurized, to be occluded, hyaloid lesion, and is soaked with interstitial lymphocyte Moisten, sees protein cast in the renal tubule of part.Each treatment group's glomerulosclerosis degree is more substantially reduced than model group (P < 0.05), according to Secondary is the natural cicada fungus groups of B group > A group > Cozaar groups >, and A groups, B groups compare no difference of science of statistics (P > with natural cicada fungus group 0.05)。
Comparison of the single-composition Chinese medicine preparation and cordyceps mycelia of 5 embodiment 2 of embodiment to renal function
The present embodiment data quoted from:The firm CSM treateds of golden Zhou Hui, Chen Yi-ping, Deng Yue delay the mechanism of action of glomerulosclerosis to grind Study carefully, Chinese combination of Chinese tradiational and Western medicine nephrosis magazine, 2005,6 (3):132-136
Tested material:The single-composition Chinese medicine preparation of embodiment 2.
Positive control drug:Cozaar, the production of Hangzhou Mo Shadong pharmaceutical Co. Ltds;Chinese caterpillar fungus hypha is purchased from Jiangxi Province's Jinshuibao Pharmaceutical Co. Ltd.
Experimental animal:Cleaning grade grade male SD rat 56,195.93 ± 20.43g of weight, by Shanghai Univ. of Traditional Chinese Medicine's reality Animal center offer is provided.
Grouping and modeling:All rat adaptable feds are randomly divided into sham-operation group 8 and modeling group 48 after 1 week.It makes Mould method:Left kidney always cuts off cortex renis weight accounts for left kidney weight 2/3 to modeling group rat for the first time;The 2nd operation is carried out after 2 weeks, The right kidney of row is cut entirely.Two operations are for cutting off the 5/6 of two kidney total weights.Sham-operation group SD rats expose kidney using same step, Detach kidney peplos, but the not nephrectomy.Modeling group rat is randomly divided into model control group, CSM treated group, Cozaar group, worm Careless mycelia group, every group each 12.Cozaar group, CSM treated group, Chinese caterpillar fungus hypha group rat start to feed after performing the operation at the 2nd time for 4 weeks Medicine, treatment time are 6 weeks.
Dosage:CSM treated group and Chinese caterpillar fungus hypha group rat press 30gkg-1·d-1Dosage be made into feed to Medicine, and often daily physiological saline gavage 1 time, record the dietary amount of rat;Cozaar group rat uses administration by gavage, by 10mg kg-1·d-1Dosage is dissolved in physiological saline, one time a day gavage.Dead 4 of model group rats in administration process, Cozaar is big Dead 2 of mouse, death does not occur for remaining each group rat.
Test equipment and method:All experimentss animal is after treatment 6 weeks, 1d whole rat limosis before putting to death, next day blood sampling, Detect the red blood cell count(RBC) (RBC) of all rats, hemochrome (Hb), packed cell volume (HCT), renal function (BUN, Scr), blood fat (TG, TC), albumin (Alb) check.The above index is measured using 7170 type automatic biochemistry analyzer of Hitachi.
After experimental animal is drawn blood, left kidney, row HE dyeing are taken out rapidly.Using medical pathologies image processing system to kidney The pathological lesion degree of bead is analyzed.It is small that every slice continuously randomly selects similar 25 kidneys of area under high power lens Ball absorb image, input Computer digital image analysis in, in system screen, calculate each Glomerular lesions involve area and The ratio of the glomerulus gross area of selection takes its mean value as the fiducial value of the glomerulus pathology extent of damage of every slice.
Data statistics is carried out using 11.0 for Windows of SPSS Version, is indicated with mean ± standard deviation, group Between compare using One-Way ANOVA analyze, statistical significance level be P < 0.05.
Test result:As a result, it has been found that CSM treated group, Chinese caterpillar fungus hypha group and Cozaar group red blood cell count(RBC), hemoglobin, Packed cell volume is above model group rats, there is significant difference (P < 0.05 or P < 0.01);Chinese caterpillar fungus hypha group and section's element The counting of subgroup Rat Erythrocytes, hemoglobin, packed cell volume are less than CSM treated group rat (P < 0.05).Model group rats BUN, Scr are apparently higher than CSM treated group (P < 0.01), Chinese caterpillar fungus hypha group and Cozaar group Scr and are above CSM treated group (P < 0.05), Cozaar group BUN be higher than CSM treated group (P < 0.05).CSM treated group rat plasma albumin is apparently higher than mould Type group rat (P < 0.01).CSM treated group rat plasma cholesterol is less than model group rats, there is significant difference (P < 0.05)。
Model group rats pathology damage is compared with CSM treated group, Chinese caterpillar fungus hypha combination Cozaar group is serious, mesangial cell proliferation Obviously, mesentery is broadening, and segment hardening or even ground-glass-like lesion occurs in part glomerulus and the whole world is hardened, and has statistics poor Different (P < 0.05 or P < 0.01);CSM treated group is compared with Chinese caterpillar fungus hypha combines Cozaar group rat, renal pathology damage Mitigate obviously, there is significant difference (P < 0.01).

Claims (4)

1. a kind of single-composition Chinese medicine preparation, the artificial cultured products of cicada fungus are contained in the single-composition Chinese medicine preparation, the cicada fungus is manually cultivated Product comprises the following steps:
1)It is prepared by strain:It is prepared and level-one kind preparation process including inclined-plane kind;
2)Inoculation:By step 1)In level-one kind obtained be linked into solid medium;
3)Fermentation:Culture box after inoculation moves in culturing room, is trained under conditions of 20 DEG C~25 DEG C, relative humidity 60%~80% It supports 30 days~50 days;
4)Harvesting;
Step 2)In, the raw material components of the solid medium include:
42~46 parts by weight of matrix;
2~10 parts by weight of bagasse;
0.1~0.5 parts by weight of oyster shell whiting;
2~5 parts by weight of dried silkworm chrysalis meal;
0.1~0.5 parts by weight of potassium nitrate;
44~56 parts by weight of water;
Wherein, the one kind of the matrix in following combination:The mixture of corn flour, wheat bran and sucrose;Wheat;Barley;Grain With the mixture of sucrose;The mixture of rice and sucrose;The mixture of sorghum and sucrose;The corn flour, wheat bran and sucrose In mixture, with the total weight of the mixture of the corn flour, wheat bran and sucrose, the weight hundred of corn flour, wheat bran and sucrose Point ratio is respectively:Corn flour 43%~55%, wheat bran 44%~55%, sucrose 1%~2%;Also contain albumen in the solid medium Peptone, and the parts by weight of the peptone are 0.5 parts by weight;The artificial cultured products of cicada fungus refer to using Paecilomyces cicadae bacterial strain The artificial cultured products that CGMCC No.3453 are obtained after above-mentioned solid culture.
2. the preparation method of single-composition Chinese medicine preparation described in claim 1, the one kind of the preparation method in following three kinds:
1)It crushes:It will directly be crushed after the artificial cultured products drying of cicada fungus, cross 120 mesh sieve and be made;
2)Solvent extraction;
3)The cicada fungus artificial culture object is added water to cook, is filtered, is concentrated into right amount, is drying to obtain xeraphium.
3. a kind of Chinese medicine composition, the Chinese medicine composition contains the folk prescription Chinese medicine system described in claim 1 of safe and effective amount Agent and pharmaceutically acceptable carrier, wherein the weight percentage of the single-composition Chinese medicine preparation is 50%-99%.
4. single-composition Chinese medicine preparation described in claim 1 is preparing treatment and is preventing chronic renal failure and the drug of other chronic kidney diseases The purposes of aspect.
CN201710259043.5A 2017-04-20 2017-04-20 A kind of single-composition Chinese medicine preparation and its preparation method and application Pending CN108721340A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710259043.5A CN108721340A (en) 2017-04-20 2017-04-20 A kind of single-composition Chinese medicine preparation and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710259043.5A CN108721340A (en) 2017-04-20 2017-04-20 A kind of single-composition Chinese medicine preparation and its preparation method and application

Publications (1)

Publication Number Publication Date
CN108721340A true CN108721340A (en) 2018-11-02

Family

ID=63925404

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710259043.5A Pending CN108721340A (en) 2017-04-20 2017-04-20 A kind of single-composition Chinese medicine preparation and its preparation method and application

Country Status (1)

Country Link
CN (1) CN108721340A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111434342A (en) * 2018-12-25 2020-07-21 葡萄王生技股份有限公司 Cordyceps cicadae mycelium active substance for preventing and/or improving acute lung injury

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111434342A (en) * 2018-12-25 2020-07-21 葡萄王生技股份有限公司 Cordyceps cicadae mycelium active substance for preventing and/or improving acute lung injury
CN111434342B (en) * 2018-12-25 2022-04-15 葡萄王生技股份有限公司 Application of cordyceps sobolifera mycelium active substance in preparation of composition for preventing and/or improving acute lung injury

Similar Documents

Publication Publication Date Title
CN103751479B (en) A kind of Cordyceps composition and method of making the same containing plant and fungus polysaccharide
CN102240301B (en) Single-composition traditional Chinese medicine preparation, and preparation method and application thereof
CN106165848A (en) Garlic skin dietary fiber and steam explosion thereof and enzymolysis modified technology of preparing and application
CN102273617A (en) Hericium erinaceus chewable tablets and preparation method thereof
CN102344872B (en) Method for preparing sweet potato yellow wine containing anthocyanidin
CN112430546A (en) Isoaerobic fermentation preparation method and application of chlamydomonas reinhardtii and chlamydomonas reinhardtii powder
CN103932180B (en) A kind ofly to release the pressure and the health food of antifatigue and two-step fermentation preparation method thereof
CN108721340A (en) A kind of single-composition Chinese medicine preparation and its preparation method and application
CN109954006A (en) A kind of single-composition Chinese medicine preparation and its preparation method and application
CN112715965A (en) Coconut dietary fiber and preparation method and application thereof
CN103932179B (en) A kind of health food and two-step fermentation preparation method thereof releasing the pressure and protect liver
CN113249227B (en) Novel lucid ganoderma strain and cultivation application thereof based on medicinal residue fungus bag
CN101591374A (en) A kind of steroidal compounds, its preparation method and contain their pharmaceutical composition and purposes
WO2021174801A1 (en) Method for preparing antrodia cinnamomea water-insoluble dietary fibers
CN112079938A (en) Highland barley polysaccharide extraction method, highland barley polysaccharide extract and application thereof
CN109893603A (en) It is a kind of to improve the composition of men&#39;s health, preparation method and applications
CN104970354B (en) A kind of reducing blood lipid and the functional food and its two-step fermentation preparation method of hypotensive
CN103263581A (en) Shuangshen capsule for reducing blood sugar
CN109430570A (en) A kind of production method of low-cholesterol egg
CN106860654A (en) A kind of utilization fruit of Chinese magnoliavine dregs of a decoction coproduction lignanoid and the method for protein feed
CN101455794B (en) Use of highland barley bran
CN105505792A (en) Hirsutella sinensis fermentation culture method
CN109619247A (en) It is a kind of with blood pressure lowering, blood lipid, the pressed candy of blood glucose and preparation method
CN118177377A (en) Composition with weight-losing and lipid-lowering effects and preparation method and application thereof
CN109221609A (en) Yellow eel feed addictive

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20181102